SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-011985
Filing Date
2023-01-20
Accepted
2023-01-20 16:05:04
Documents
15
Period of Report
2023-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d426535d8k.htm   iXBRL 8-K 28682
2 EX-1.1 d426535dex11.htm EX-1.1 205027
3 EX-5.1 d426535dex51.htm EX-5.1 8667
7 GRAPHIC g426535g0120215347845.jpg GRAPHIC 2635
  Complete submission text file 0001193125-23-011985.txt   423938

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dcph-20230119.xsd EX-101.SCH 2857
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20230119_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20230119_pre.xml EX-101.PRE 10817
9 EXTRACTED XBRL INSTANCE DOCUMENT d426535d8k_htm.xml XML 3221
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 23540973
SIC: 2834 Pharmaceutical Preparations